In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

Merck KGAA to buy Serono for CHF16.6bn

Executive Summary

Merck KGAA has agreed to acquire Geneva-based biotech Serono SA in a deal valued at CHF16.6bn ($12.9bn). Merck will initially buy out majority shareholders the Bertarelli family, which accounts for a 64.5% stake in Serono; the company plans to continue with a public tender offer in 2007 to acquire the remaining shares.
Deal Industry
  • Biotechnology
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Acquisition
    • Payment Includes Cash
    • Full Acquisition

Related Companies

Advertisement
UsernamePublicRestriction

Register